Over 20 years of experience in preclinical CRO business

Virtual CRO: Oncology and immuno-oncology

Model selection of our oncology CRO partners covers both oncology and immuno-oncology studies. Due to high demand, new models are developed constantly, and co-development of customized models is supported. New models are developed for example to expand patient-derived xenograft (PDX) collections, to establish orthotopic and metastasis models from cell line -derived xenografts (CDX), and generating new data for reference compounds. Our CRO partners have a strong experience in working with many types of therapies including small molecules, biologics, cell-based therapies and vaccines.

Overview of available oncology and immuno-oncology models:

  • CDX models in metastatic, orthotopic and subcutaneous settings
  • Specialty CDX models for bone metastasis
  • Patient-derived xenograft (PDX) models
  • Syngeneic and humanized mouse models for immuno-oncology
  • In vitro and ex vivo assays

 Contact us to learn more about this opportunity.



If you are interested to learn more,
see our services or contact us directly. logo Science Exchange logo

    Copyright © 2024 OncoBone Ltd